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ABSTRACT
Background
Patients with high blood pressure (hypertension) in the
community frequently fail to meet treatment goals: a
condition labelled as ‘uncontrolled’ hypertension. The
optimal way to organise and deliver care to hypertensive
patients has not been clearly identified.
Aim
To determine the effectiveness of interventions to
improve control of blood pressure in patients with
hypertension.
Design of study
Systematic review of randomised controlled trials.
Setting
Primary and ambulatory care.
Method
Interventions were categorised as following: self-
monitoring; educational interventions directed to the
patient; educational interventions directed to the health
professional; health professional- (nurse or pharmacist)
led care; organisational interventions that aimed to
improve the delivery of care; and appointment reminder
systems. Outcomes assessed were mean systolic and
diastolic blood pressure, control of blood pressure and
proportion of patients followed up at clinic.
Results
Seventy-two RCTs met the inclusion criteria. The trials
showed a wide variety of methodological quality. Self-
monitoring was associated with net reductions in systolic
blood pressure (weighted mean difference [WMD]
–2.5mmHg, 95%CI = –3.7 to –1.3 mmHg) and diastolic
blood pressure (WMD –1.8mmHg, 95%CI = –2.4 to
–1.2 mmHg). An organised system of regular review allied
to vigorous antihypertensive drug therapy was shown to
reduce blood pressure and all-cause mortality in a single
large randomised controlled trial.
Conclusion
Antihypertensive drug therapy should be implemented by
means of a vigorous stepped care approach when
patients do not reach target blood pressure levels. Self-
monitoring is a useful adjunct to care while reminder
systems and nurse/pharmacist -led care require further
evaluation.
Keywords
hypertension; prevention and control; primary care;
systematic review.
INTRODUCTION
Hypertension is largely managed in primary care and
is an important public health problem in terms of
associated stroke and cardiovascular events. It is
mostly of unknown aetiology, easy to diagnose, and
readily preventable by blood pressure reduction.
Extensive epidemiological data have strengthened
the well-recognised relationship between blood
pressure and risk of cardiovascular disease, and
have confirmed the importance of systolic blood
pressure as a determinant of risk.1 However, blood
pressure goals are achieved in only 25–40% of the
patients who take antihypertensive drug treatment,2,3
which is something that has remained unchanged for
the last 40 years.4
Use of self-monitoring of blood pressure by
patients and professionals has gained popularity and
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is now recommended in particular patients in certain
national and international guidelines; a recent meta-
analysis of randomised trials on the subject did
suggested a benefit in terms of mean blood pressure
and blood pressure control.5 This systematic review
aims to update and build upon previous reviews,6,7 by
summarising the evidence from randomised
controlled trials (RCTs) that evaluate non-
pharmacological interventions to improve the
management of hypertension in primary care.
METHOD
Searching and study selection
Studies of patients aged >18 years with essential
hypertension in an ambulatory setting were included.
The interventions comprised all those that aimed to
improve blood pressure control by non-
pharmacological means and were classified as:
• self-monitoring;
• educational interventions directed to the patient;
• educational interventions directed to the health
professional;
• nurse- or pharmacist-led care;
• organisational interventions that aimed to improve
the delivery of care; or
• appointment-reminder systems.
The outcomes assessed were mean systolic and
diastolic blood pressure, control of blood pressure,
and the proportion of patients followed up at clinic.
Original RCTs were identified by an all-language
search in February 2008 of all articles (any year) in
the Cochrane Controlled Trials Register and Medline
(search strategy shown in Appendix 1); articles dated
from January 1980 were searched on Embase.
Included studies had to be RCTs with a
contemporaneous control group, where patient care
in the intervention group(s) was compared with either
no intervention or usual care.
Data extraction and analysis
Two of the authors assessed lists of citations and
abstracts independently. Differences were resolved
by discussion and final adjudication was performed
by an additional two authors. Reprints of all
potentially relevant citations were obtained and data
were independently extracted in duplicate using a
structured data-collection form. Study quality was
assessed by collection of data on inclusion and
exclusion criteria; randomisation procedure;
allocation concealment; blinding of participants,
providers of care, and outcome assessors; and
losses to follow-up.8
The effects on blood pressure outcomes of the six
pre-defined intervention categories outlined above
were examined. For the outcomes of mean systolic
and diastolic blood pressure, pressure differences
from baseline to final follow-up in the intervention and
control groups were compared and pooled using the
weighted mean difference approach.7 For the
outcomes of blood pressure control and clinic
attendance at follow-up, statistical and clinical
significance was evaluated by means of estimating
odds ratios (ORs) with 95% confidence intervals (CIs).
Individual study definitions of control of blood
pressure and attendance at clinic were used. For both
continuous and categorical outcomes, the meta-
analyses for heterogeneity were checked by visual
inspection and by Cochran’s C test. Pooled ORs and
their 95% CIs were calculated with The Cochrane
Collaboration RevMan software (version 5.02).
RESULTS
Trial flow, study characteristics, and quality
assessment
The flow of studies through the stages of the
systematic review is shown in Figure 1. A total of 72
trials were included in this systematic review
(Characteristics of included randomized controlled
trials are described in Appendix 2). The reported
methodological quality of included studies was
generally poor to moderate. The randomisation
process was described in 30 (42%) of the 72 trials
included, while only 14 (19%) had adequate
allocation concealment. In 15 studies (21%), the
outcome assessors were blind to the treatment
allocation and losses to follow-up of 20% or more
occurred in 18 (25%) of studies.
Intervention effects
The impact of interventions is summarised in Table 1
(full data available from authors). There was
substantial heterogeneity for several interventions
and outcomes. In these situations, pooled data are
not reported but the range of results from individual
RCTs are presented.
How this fits in
The majority of patients with hypertension who take blood pressure medication
fail to reach treatment goals. There is a strong evidence base for the benefits of
antihypertensive drug therapy, but there is a lack of clarity on how to organise
and deliver care for patients with hypertension in the community. This
systematic review of 72 randomised controlled trials shows that self-monitoring
leads to a significant decline in systolic and diastolic blood pressure and, as
such, may be a useful adjunct to care and is likely to lead to a reduction in
cardiovascular events. An organised system of regular review allied to vigorous
antihypertensive drug therapy was shown to reduce blood pressure and all-
cause mortality. Nurse- or pharmacist-led care and appointment-reminder
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Self-monitoring
With regard to self-monitoring (n = 18 RCTs), pooled
data from 12 RCTs that reported on differences in
mean systolic blood pressure8–19 showed that self-
monitoring was associated with a significant
reduction of –2.5 mmHg (95% CI = –3.7 to
–1.3 mmHg). Pooled data from 14 RCTs on
difference of mean diastolic blood pressure,9–22
showed that self-monitoring was associated with a
reduction of –1.8 mmHg (95% CI = –2.4 to
–1.2 mmHg). In the six RCTs that reported on control
of blood pressure,10,12,18,22–24 there was no significant
improvement in blood pressure control seen (OR 1.0,
95% CI = 0.8 to 1.2).
Educational interventions
Educational interventions directed to the patient
involved 20 RCTs. Eleven RCTs reported mean
difference systolic blood pressure,25–35 13 RCTs
reported mean difference diastolic blood
pressure,25–38 and seven reported blood pressure
control.22,23,30,32,33,39,40 For mean difference in systolic
blood pressure and diastolic blood pressure
outcomes, pooling of results from individual RCTs
produced substantial heterogeneity, so pooled mean
differences are not valid. The reported mean
difference in systolic blood pressure ranged from
–16 mmHg to 1 mmHg, and from –9 mmHg to 7
mmHg for mean difference in diastolic blood
pressure. In terms of blood pressure control, there
was a trend towards improved blood pressure
control and this was significant (OR 0.83; 95% CI =
0.75 to 0.91). Educational interventions directed
towards the physician (n = 10 RCTs)30,41–49 were not
associated with a significant decrease in mean
systolic blood pressure or diastolic blood pressure;
control of blood pressure produced heterogeneous
results (OR ranged from 0.8 to 1.1).
Nurse- or pharmacist-led care
For nurse- or pharmacist-led care (n = 12 RCTs),50–61
the majority of RCTs were associated with improved
blood pressure control. However, for all three
outcomes, the pooling of results from individual
RCTs produced substantial heterogeneity, so pooled
mean differences may not be valid. The range of
mean difference was from –13 mmHg to 0 mmHg in
mean systolic blood pressure (n = 10 RCTs) and from
–8 mmHg to 0 mmHg for diastolic blood pressure
(n = 12 RCTs); control of blood pressure (n = six
RCTs) produced ORs ranging from 0.1 to 0.9.
Organisational interventions
Organisational interventions that aimed to improve
the delivery of care were described in nine
RCTs.40,41,60–69 For all three outcomes, pooling of
results from individual RCTs produced
heterogeneous results, so pooled mean differences
may not be valid. Of note, the largest RCT, the
Hypertension Detection and Follow–Up Program
(HDFP),64 produced substantial reductions in systolic
blood pressure and diastolic blood pressure across
the three groups (weighted mean difference
–8.2/–4.2 mmHg, –11.7/–6.5 mmHg, –10.6/–7.6
mmHg for the three strata of entry blood pressure).
Appointment-reminder systems
For appointment-reminder systems (n = 8 RCTs),70–77
the pooled results — although favouring the
intervention for follow-up of patients (OR of being
lost to follow-up 0.4, 95% CI = 0.3 to 0.5) — are
heterogeneous because of the single outlying RCT,
and the pooled results should be treated with
caution. Pooled data from two small RCTs — one a
three-armed study of telephone reminder, mailed
reminder, and usual care,76 and the other a parallel
study of SMS reminder versus usual care77 — gave
heterogeneous results in terms of systolic and
Studies identified and
retrieved by search strategy
for screening 
(n = 9531)
Studies excluded with reasons
(total n = 9262):
Not an RCT (n = 3017)
Didn’t meet inclusion criteria (n = 5279)
Hospital based study (n = 966)
Studies retrieved for more
detailed evaluation
(n = 269) Studies excluded with reasons
(total n = 110):
Not an RCT (n = 27)
Didn’t meet inclusion criteria (n = 55)
Not usual care arm (n = 6)
Outcome not relevant  (n = 22)Potentially appropriate RCTs
to be included in the
meta-analysis
(n = 159) Potentially appropriate RCTs excluded from meta-analysis, with reasons
(total n = 87):
Not properly randomised (n = 39)
Not ambulatory care setting (n = 3)
No usual care arm (n = 5)
No relevant outcome (n = 19)
Not hypertensive patients (n = 7)
Lifestyle advice intervention (n = 7)
Duplicate publication (n = 7)
RCTs included in the meta-analysis (n = 72)
Inteventions and outcomes in RCTs categorised as follows:
• Self monitoring (n = 18), SBP (n = 10), DBP (n = 12), BP control (n = 4),
no usable outcome data (n = 1)
• Education- patient (n = 20), SBP (n = 7), DBP (n = 9), BP control (n = 5),
no usable outcome data (n = 3)
• Education- health professional (n = 10), SBP (n = 6), DBP (n = 6),
BP control (n = 6), no usable outcome data (n = 0)
• Nurse or pharmacist led care (n = 12), SBP (n = 5), DBP (n = 6),
 BP control (n = 5), no usable outcome data (n = 2),
• Organisation of care (n = 9), SBP (n = 5), DBP (n = 5), BP control (n = 5),
no usable outcome data (n = 2)
• Appointment reminders (n = 8), Appointment follow up (n = 6),
no usable outcome data (n = 0)
*72 unique randomised controlled trials met the inclusion criteria. Four of these trials had single or multiple
companion publications or studies associated with them giving a total of 77 studies included in the analysis under
the headings above.
Figure 1. Flow chart for
studies through stages of
systematic review.
BP = blood pressure. DBP = diastolic blood pressure. RCT = randomised controlled trial.
SBP = systolic blood pressure.
Systematic Review
diastolic blood pressure, but did show a significant
improvement in blood pressure control, OR 0.5 (95%
CI = 0.4 to 0.7).
DISCUSSION
In this systematic review, self-monitoring was
associated with a significant decline in systolic blood
pressure (–2.5 mmHg) and diastolic blood pressure
(–1.8 mmHg). Although this blood pressure reduction
does not appear substantial in clinical terms, it
would, nonetheless, appear to be a useful adjunct to
care and is likely to lead to a reduction in mortality
and cardiovascular events. This appears to be
confirmed in the HDFP study65,66 where an organised
system of regular review allied to vigorous
antihypertensive drug therapy was shown to reduce
blood pressure as well as all-cause mortality.
At 5-year follow-up, the reductions in blood
pressure (~10 mmHg for systolic blood pressure and
5 mmHg for diastolic blood pressure) seen in this
study were associated with a significant reduction in
all-cause mortality (6.4% versus 7.8%, absolute risk
reduction = 1.4%, numbers needed to treat = 71).
Nurse- or pharmacist-led care and appointment-
reminder systems may be a promising way of
improving blood pressure control, but require further
evaluation.
A previous meta-analysis of self-monitoring
produced similar findings to the current study of
modest, but potentially important, benefit in systolic
and diastolic blood pressure.5 This is important in
light of the fact that self-monitoring is now practised
by up to two-thirds of the population that has
hypertension in the US and Europe.78
There are also other elements identified from this
review that appear to be associated with improved
blood pressure control and are consistent with
findings from observational studies and previous
systematic reviews. A more recent observational
study showed that antihypertensive drug therapy
was initiated or changed in only 38% of episodes of
care, despite documented uncontrolled hypertension
for at least 6 months.79 Lack of practice organisation
is associated with a failure to achieve treatment
surrogate goals in hypertension, diabetes, and
secondary prevention of coronary heart disease.80
This review had several limitations. Several RCTs
included patients with hypertension who were
treated and untreated and had differential rates of
antihypertensive drug prescribing.8,18,47,76 Many RCTs
contained multifaceted interventions that did not fit
into a single intervention category.40,51,67
Consequently, it has been difficult to attribute how
far single elements that make up complex
interventions exert their independent effect on blood
pressure control. Finally, several of the RCTs did not
make any recommendations about the need for
adjustment of target blood pressure readings when
self-monitoring was the intervention being assessed,
nor did they appear to anticipate lower blood
pressure readings in the self-monitoring group.16,21,22,24
This may have attenuated the impact of self-
monitoring on blood pressure control because of
failure to intensify treatment. Self-monitoring of
blood pressure by patients and blood pressure
management by allied healthcare professionals both
require further development and evaluation in larger
RCTs and prospective studies, including
cardiovascular outcomes.
This systematic review does, however, confirm
that the most effective way to manage hypertension
in the community is through a structured approach
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Systolic blood pressure, mmHg Diastolic blood pressure, mmHg Blood pressure control, ORa
Pooled estimate Range of results Pooled estimate Range of results Pooled estimate Range of results
Intervention (95% CI) from individual RCTs (95% CI) from individual RCTs (95% CI) from individual RCTs
Self-monitoring –2.5 (–3.7 to –1.3)b –10 to 5 –1.8 (–2.4 to –1.2)b –12 to 0 1.0 (0.8 to 1.2) 0.5 to 1.3
Education (patient) c –16 to 1 c –9 to 7 –0.8 (0.8 to 1.0)a 0.3 to 1.1
Education (physician) –2.0 (–3.5 to –0.6)b –7 to 1 –0.4 (–1.1 to 0.3) –2 to 1 0.9 (0.8 to 0.9) 0.8 to 1.0
Nurse- or pharmacist-led care c –13 to 0 c –8 to 0 c 0.1 to 0.9
Organisational interventions c –12 to 3 c –8 to 5 c 0.5 to 1.8
Appointment reminders c –10 to 5 c –7 to 2 0.5 (0.4 to 0.7)a 0.5 to 0.6
Follow-up at clinic (RR)
Pooled estimate Range of results
Intervention (95% CI) from individual RCTs
Appointment reminders c 0.1 to 1.4
aOR of control of blood pressure (‘control’ blood pressure threshold definition taken as that used in each individual RCT), RR <1 blood pressure control greater
in intervention group, >1 blood pressure control greater in control group. bP<0.05, heterogeneous results. cNo pooled estimate reported. OR = odds ratio. RCT =
randomised controlled trial. RR = relative risk.
Table 1. Summary of results of interventions on systolic and diastolic blood pressure, blood pressure
control and follow-up at clinic.
British Journal of General Practice, December 2010
LG Glynn, AW Murphy, SM Smith, et al
e480
combining systematic identification and follow-up,
which will include patient self-monitoring allied
with appropriate treatment with antihypertensive
medications.
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1 exp Hypertension/ (167533) 38 Motivation/ (34065)
2 (blood adj pressure).ti. (33263) 39 self monitor$.tw. (2518)
3 hypertens$.ti. (120524) 40 ((patient$ or program$) adj3 (educat$ or manage$ or train$
4 or/1–3 (208545) or teach$)).tw. (121066)
5 exp physicians/ (62183) 41 self manage$.tw. (3390)
6 exp Patient Care Management/ (351254) 42 ((manage$ or monitor$) adj3 (hypertension or
7 exp Patient Care Planning/ (40740) blood pressure)).tw. (9858)
8 exp Patient Care Team/ (40160) 43 Health Promotion/ (31545)
9 exp Patient Education/ (50057) 44 exp Health Education/ (102113)
10 exp Patient Participation/ (11975) 45 (reward$ or incentive$).tw. (25369)
11 exp Ambulatory Care Information Systems/ (1034) 46 uncontrol$.tw. (17033)
12 exp Feedback/ (21503) 47 Self Care/ (14858)
13 exp Information Systems/ (98899) 48 or/5–47 (1087894)
14 exp Management Information Systems/ (27680) 49 4 and 48 (19344)
15 exp Decision Support Systems, Clinical/ (2297) 50 randomized controlled trial.pt. (246660)
16 exp Decision Making, Computer–Assisted/ (46651) 51 controlled clinical trial.pt. (76052)
17 exp Reminder Systems/ (1144) 52 Randomized Controlled Trials/ (51847)
18 exp Practice Guidelines/ (42659) 53 random allocation/ (59418)
19 exp Guidelines as topic/ (64954) 54 double blind method/ (94259)
20 exp Medical Audit/ (10918) 55 single blind method/ (11548)
21 exp Medical Records/ (56232) 56 or/50–55 (416351)
22 exp Medical Records Systems, Computerized/ (13174) 57 animal/ not human/ (3141649)
23 exp Primary Health Care/ (49856) 58 56 not 57 (390135)
24 exp Physicians, Family/ (11443) 59 clinical trial.pt. (439482)
25 exp Primary Nursing Care/ (1868) 60 exp clinical trials as topic/ (197049)
26 exp Nurse Practitioners/ (11902) 61 (clin$ adj25 trial$).ti,ab. (139080)
27 exp Nurse Clinicians/ (6234) 62 ((singl$ or doubl$ or treble$ or tripl$) adj25
28 exp Health Behavior/ (58847) (blind$ or mask$)).ti,ab. (93517)
29 remind$.tw. (6318) 63 placebos/ (26524)
30 motiv$.tw. (41873) 64 placebo$.ti,ab. (106301)
31 Patient Care/ (4501) 65 random$.ti,ab. (393128)
32 Nursing Care/ (24234) 66 research design/ (50559)
33 Guideline Adherence/ (9258) 67 or/59–66 (882479)
34 Ambulatory Care/ (28816) 68 67 not 57 (818962)
35 exp Behavior Therapy/ (35585) 69 58 or 68 (840420)
36 Counseling/ (21055) 70 49 and 69 (4661)
37 counsel$.tw. (40826)
aSearch slightly amended for Cochrane Central Register of Controlled Trials (CENTRAL) and Embase.
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RCT Population Intervention Outcomea Interpretation
McManus 441 people receiving treatment in (1) Patients in the intervention group received SBP –2.30 (–5.39 to 0.79) Positive for SBP
et al15 primary care for hypertension treatment targets along with facilities to DBP –1.10 (–2.75 to 0.55)
but not controlled below the target measure their own blood pressure at their Control not reported
of <140/85 mm Hg. general practice; they were also asked to visit
their GP or practice nurse if their blood
pressure was repeatedly above the target level.
(2) Patients in the control group received usual care
Bailey Patients with hypertension about (1) Self-monitoring: use of an Omron SBP 5.0 (–4.7 to 14.7) No effect SBP, positive effect
et al18 to start BP-lowering treatment HEM706 monitor. Asked to record BP DBP –2.0 (–3.4 to –0.6) DBP. Physicians in
twice daily for 8 weeks Control not reported intervention group not
(2) Usual care: no self-recording instructed to adjust for
self-monitored BP readings
Carnahan Patients with hypertension starting (1) Self-monitoring: instructed to use own SBP –7.5 (–14.2 to –0.8) Positive effect SBP,
et al16 treatment in hospital clinic sphygmomanometer twice a day. DBP 0 (–3.9 to 3.9) no effect DBP
Readings recorded and delivered to Control not reported
the clinic when visiting
(2) Usual care
Friedman Taking BP-lowering drugs, SBP (1) Home monitoring and SBP –4.0 (–3.9 to 3.1) No effect SBP,
et al13 ≥160 mmHg or DBP ≥90 mmHg telecommunication system DBP –4.4 (–6.5 to –2.3) positive effect DBP
on average two readings • Weekly automated home blood Control not reported
pressure recording
• Telephone-linked computer system to patient
(2) Usual care
Haynes Males with hypertension not (1) Patient self-monitoring and education SBP not reported No effect DBP
et al21 compliant or at goal DBP (2) Usual care DBP –3.5 (–7.0 to 0.1)
(≥90 mmHg) Control not reported
Johnson All taking BP-lowering (1) Self-recording SBP not reported No effect RCT
et al22 medication for ≥1 year with (2) Home visit: BP measured in DBP –1.0 (–5.7 to 3.7)
uncontrolled hypertension their homes every 4 weeks with result Control not reported
(DBP≥95 mmHg) given to them and physician. Both
groups visited at home after 2 weeks
(3) Both interventions
(4) Neither intervention
Mehos People with uncontrolled (1) Home blood pressure monitoring SBP –10.1 (–19.8 to –0.4) No effect SBP,
et al19 hypertension SBP 140–179 mmHg (2) Usual care DBP –6.7 (–13.2 to –0.3) positive effect DBP
and/or DBP 90–109 mmHg Control not reported
Pierce People with uncontrolled (1) Self-monitoring SBP not reported No effect RCT
et al23 hypertension (SBP ≥160 and/or (2) Health-education programme DBP not reported (self-monitoring arm)
DBP ≥95 mmHg) (3) Both interventions Control 1.2 (0.6 to 2.7)
(4) Usual care
Rogers Change in BP medication because: (1) Telecommunication service with three SBP –4.8 (–9.8 to 0.2) No effect SBP,
et al12 (1) SBP ≥140 or DBP ≥90 mmHg components: automated BP at home; DBP –4.0 (–7.7 to –0.3) positive effect DBP,
(2) Side-effects from drugs central processing of BP readings; weekly Control 1.1 (0.5 to 2.3) no effect control of
(3) SBP >180 or DBP >110 without reports to both physician and patient blood pressure
current antihypertensive therapy (2) Usual care
Soghikian Hypertension but no entry BP level (1) Home blood pressure measurement: SBP –3.3 (–6.4 to –0.2) Positive effect SBP,
et al17 required or defined patients asked to measure BP twice weekly, DBP –1.6 (–3.5 to to 0.3) no effect DBP
mail record of BP, medications and side Control not reported
effects to project office every 4 weeks
(2) Usual care
Vetter20 Hypertension, SBP 160–200 mmHg (1) Home measurement of blood pressure SBP –0.5 (–2.8 to 1.8) No effect SBP, positive effect
or DBP 95–115 mmHg in patients by patients DBP –1.3 (–2.4 to –0.2) DBP, no effect on control of
who are untreated or uncontrolled (2) Usual care Control 0.8 (0.6 to 1.1) blood pressure
Baqu Patients with poorly controlled (1) The patients were given an OMRON SBP not reported No effect for blood pressure
et al25 essential hypertension, defined as HEM-705CP automatic blood pressure monitor DBP not reported control
systolic blood pressure > or = 140 on two occasions, for use during 15 days at Control 1.21 (0.94 to 1.58)
or diastolic blood pressure > or = weeks 6 and 14. Blood pressure was recorded
90 mmHg. at each visit (baseline, 6, 8, 14, 16, and 24 weeks)
(2) Usual care
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Zarnke26 Average BP readings <160/95 mmHg (1) Patient-directed group: instructed in SBP not reported Positive RCT mean arterial
taking BP lowering drugs or home BP measurement, measured own BP DBP not reported BP improved by –3 mmHg
receiving non-pharmacological twice daily and instructed by means of Control not reported at 8 weeks follow-up
advice algorithm to change own BP medication
(2) Usual care
Artinian Hypertension, SBP ≥140 mmHg (1) Home BP telemonitoring: self- SBP –26.0 (–40.0 to 11.6) No effect RCT (pilot study
et al11 or ≥90 mmHg or for patients with monitoring at home and transmitting BP DBP –12.0 (–21.5 to –2.5) with short follow-up period




Midanik Untreated patients with (1) Self-monitoring: patients trained to take SBP –2.0 (–7.4 to 3.4) No effect RCT
et al9 hypertension: SBP <180 mmHg two consecutive readings twice a week. DBP 0 (–2.9 to 2.9)
and DBP 90–99 mmHg Sent in readings every 4 weeks for 1 year Control not reported
(2) Usual care
Rudd Hypertension: SBP ≥140 mmHg (1) Self-measurement with nurse SBP –8.5 (–14.3 to –2.7) Positive RCT for SBP
et al10 or DBP ≥90 mmHg in previous management based on algorithm DBP –3.1 (–6.0 to –0.2) and DBP
6 months or history of drug (2) Usual care Control not reported
treatment
Earp Hypertension treated at outpatient (1) Home visits: over 18 months by nurse SBP not reported No effect RCT
et al24 hypertension clinic or general or pharmacist. DBP not reported
practice clinic (2) Home visits plus involvement of Control 1.3 (0.6 to 2.7)
‘significant other’ — involved daily/
several times a week BP monitoring
(3) Usual care
Billault Attended hypertension clinic, no (1) Booklet with personalised standardised SBP –1.1 (–5.8 to 3.6) No effect RCT
et al27 entry SBP/DBP defined medical information explained to patient DBP 1.4 (–1.5 to 4.3)
and their family doctor Control not reported
(2) Usual care
Burelle Uncontrolled and non-adherent (1) TIME: home visits, education SBP –7.4 (–22.5 to 7.7) No effect RCT,
et al28 patients with hypertension education and special dosing devices DBP 7.1 (–5.2 to 19.4) very small study
(2) Usual care Control not reported
Cakir et al29 Persons with hypertension (mean (1) Patient education (‘lifestyle intervention’) SBP –10.0 (–15.0 to –5.0) Positive for SBP and DBP
systolic BP of 140 mmHg and/or while participants in the (2) control group DBP –8.6 (–12.3 to –4.9)
mean diastolic BP, DBP, of were provided with routine outpatient services Control not reported
90 mmHg on 3 separate occasions and were asked to maintain their usual
during a 3-week period), lifestyles, including dietary and exercise habits,
and aged 18–65 years for 6 months until they were reexamined.
Fielding Hypertension, either: SBP ≥140 • (1) IMPACT consisted of monthly SBP –8.5 (–14.8 to –2.2) Positive RCT
et al30 and/or DBP ≥90 mmHg 10-minute individual sessions for DBP –3.9 (–7.1 to –0.7)
patients with counsellor Control not reported
(2) Usual care
Hennessy Total of 10 696 patients with a (1) Academic detailing, provision of Patient education No effect RCT
et al31 diagnosis of hypertension cared provider-specific data about hypertension BP 0.00 (–0.73 to 0.73)
for by 93 primary care providers. control, provision of educational materials to DBP 1.00 (0.56 to 1.44)
Randomised by provider (n = 93), the provider, and provision of educational Control 0.83 (0.76 to 0.92)
analysed by patient (n = 7159). and motivational materials to patients. Physician education
(2) Usual care SBP 0.00 (–0.73 to 0.73)
DBP 1.00 (0.56 to 1.44)
Control 0.83 (0.76 to 0.92)
Morisky BP (mmHg) entry criteria based (1) Three interventions: exit interview; SBP not reported Improved BP control but
et al40 on age: 20–39: >140/90 instructional session on adherence and DBP not reported substantially greater
40–59: >150/95 follow-up care; group sessions Control 0.6 (0.4 to 0.9) numbers lost to follow-up in
≥60: ≥160/100 (2) Usual care (C) arm at 2 and 5 years
Mühlhauser Hypertension (mean last two (1) Hypertension treatment and teaching SBP –5.0 (–9.3 to –0.7) Positive RCT for SBP/DBP,
et al34 measurements ≥160 and/ programme DBP –3.0 (–0.4 to –0.6) no effect on control of BP
or ≥95 mmHg). (2) Usual care Control 1.1 (0.4 to 2.6)
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Hunt Patients with mildly uncontrolled Patients randomised to intervention (1) were SBP –2.00 (–4.70 to 0.70) No effect on SBP, DBP
et al32 hypertension as defined as a last mailed two educational packets approximately DBP –2.00 (–4.25 to 0.25)
blood pressure of 140 to 159/90 3 months apart. (2) The control group Control not reported
to 99 mmHg from query of an consisted of similar patients receiving
electronic medical record database. usual care for hypertension.
McKinstry Parallel, single blind, Single urban (1) Patient-held guideline with written explicit SBP –1.00 (–5.73 to 3.73) No effect for SBP or
et al33 general practice over 1 year in the exhortation to challenge care when appropriate.DBP –2.00 (–4.63 to 0.63) blood pressure control
UK of patients with hypertension. (2) Usual care Control 0.98 (0.60 to 1.60)
Roca- Newly diagnosed patients with (1) Patient education: booklet; educational SBP1.3 (–4.3 to 6.9) No effect RCT
Cusachs hypertension. Mean values were: talks; personal tutorial DBP 1.9 (–1.1 to 4.9)
et al35 (E) 156.3/95.8 (2) Usual care Control not reported
(C) 160.3/96.1
Sackett Hypertension ≥95 mmHg (1) Augmented convenience site SBP not reported No effect RCT
et al41 physician care DBP not reported
(2) Mastery learning: via audio-cassette Control 0.7 (0.3 to 2.1)




Tanner Hypertension DBP ≥90 mmHg (1) Intervention group: booklet SBP not reported No effect RCT
et al38 (2) Usual care DBP 0.2 (–4.7 to 5.1)
Control not reported
Watkins Hypertension (1) Information booklet on hypertension SBP 0.6 (–3.0 to 4.2) No effect RCT
et al36 sent out to patients DBP 0.4 (–1.4 to 2.2)
(2) Usual care Control not reported
Webb Hypertension; DBP≥90 mmHg (1) Education: three group education SBP not reported No effect RCT
et al39 sessions by nurse-health educator DBP –3.3 (–7.0 to 0.4)
(2) Counselling: three ‘individualised’ Control not reported
counselling sessions
(3) Usual care: three appointments
with family physician
Zismer Hypertension or ≥140 or (1) Experimental group A: educational SBP –15.7 (–26.0 to –5.4) Positive RCT for SBP/DBP
et al36 ≥90 mmHg ‘self-care’ intervention: pill taking; DBP –8.7 (–15.5 to –1.9)
appointment keeping; dietary sodium Control not reported
reduction
(2) Experimental group B-received
additional support from family member
(3) Usual care
Coe Hypertension mean BP (1) Computer-generated treatment SBP –1.2 (–10.1 to 7.7) No effect RCT
et al43 >140/95 mmHg recommendations by algorithm DBP 1.1 (–3.6 to 5.8)
(2) Usual physician care Control not reported
Dickinson Mean baseline BP 159/89 mmHg (1) Computer-generated feedback-monthly SBP 1.0 (–8.3 to 10.3) No effect RCT but improved
et al42 feedback reports DBP –1.0 (–6.9 to 4.9) follow-up at clinic




Evans Hypertension DBP >90 mmHg (1) Mailed continuous to physicians 14 weekly SBP 0.8 (–4.2 to 5.8) No effect RCT
et al44 medical education instalments of information, DBP 0.3 (–2.0 to 2.6)
chart and follow-up appointment system to Control 0.8 (0.5 to 1.5)
encourage detection and recall of patients
(2) Usual care
Hetlevik Patients with hypertension (1) Computer-based decision support system. SBP –1.5 (–3.2 to 0.2) No effect RCT
et al45 Re-enforcement by mean of telephone DBP –0.6 (1.4 to 0.2)
repetitions seminar on risk intervention Control not reported
(2) Usual care
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McAllister Patients with hypertension: (1) Compute-generated feedback to SBP not reported No effect RCT
et al46 (1) DBP >90 mmHg on treatment physician on individual patient; inter and DBP not reported
(2) DBP >104 mmHg not on intra practice DBP ranking; commentary Control 0.9 (0.5 to 1.4)
treatment. (3) DBP >90 or on treatment by GP according to a
<105 mmHg with complications ‘stepped-care’ approach.
or risk factors (2) Control group filled out same forms
but no feedback given
Montgomery Patients with hypertension aged (1) Computer-based decision support system SBP –4.0 (–8.3 to 0.3) No effect RCT
et al47 60–80 years taking BP-lowering (2) Risk chart DBP 1.0 (–1.2 to 3.2)
drugs (3) Usual care Control 1.0 (0.7 to 1.6)
Ornstein Hypertension: Uncontrolled/ (1) Multi-method quality improvement SBP not reported Positive RCT (for BP control
et al48 untreated >140/90 mmHg or • Practice site visits DBP not reported but not for many of the other
on treatment. At baseline • 2-day network meetings in each study year Control 0.8 (0.7 to 0.9) quality indicators)
40% (E) and 43.7% (C) had (2) Usual care: received copies of practice
‘controlled’ BP guidelines and quarterly performance reports
(<140/90 mmHg)
New Patients with diabetes and (1) Educational outreach delivered by SBP not reported No effect RCT
et al49 hypertension (>140/80 mmHg) specialist nurses DBP not reported
(2) Usual care Control 1.0 (0.9 to 1.1).
Sanders Patients with diabetes and (1) Chart reminder SBP –6.8 (–11.3 to –2.3) No effect RCT
et al50 hypertension (BP level not defined) (2) Usual care DBP –2.1 (–4.8 to –0.6)
Control not reported
Bogden Hypertension, either: (1) Pharmacist interacted with physicians SBP –12.0 (–20.1 to –3.4) Positive RCT
et al51 ≥150 or ≥95 mmHg and patients according to pre-specified DBP –8.0 (–12.0 to –0.7)
≥140 or ≥90 mmHg with CVS risk checklist Control 0.2 (0.1 to 0.5)
factors or target organ damage (2) Control: usual medical care
Garcia–Pena Hypertension, mean SBP ≥160 (1) Nurse-based intervention: nurses trained SBP –3.3 (–5.9 to –0.7) Positive RCT
et al52 or/both DBP ≥90 in aging and clinical aspects of hypertension DBP –3.7 (–5.1 to –2.3)
(2) Usual care from institute’s clinic and Control 0.1 (0.1 to 0.2)
mailed pamphlet about hypertension
Hawkins Hypertension OPD clinic US (1) Clinical pharmacist: chronic disease SBP 0.0 (–1.9 to 1.9) No effect RCT but improved
et al53 (42% E) (49% C) management in OPD setting (medical care DBP 0.0 (–0.7 to 0.7) follow-up at clinic
monitored by general practice faculty) Control not reported
(2) Usual care by physician
Jewell New diagnosis DBP >100 mmHg (1) Nurse-led care. Agreed protocol SBP not reported No effect RCT
et al54 aged 30–39 years, determined treatment and frequency of DBP not reported
>105 mmHg aged >40 years attendance in both groups. Target was to Control 0.9 (0.2 to 3.6)
Uncontrolled DBP >95 mmHg reduce DBP <90 mmHg
(2) Usual care using same protocol
Logan Hypertension (DBP ≥95 mmHg, or (1) Work-site care by nurse management SBP not reported Positive RCT for DBP
et al55 DBP 91–94 mmHg and SBP protocol: including drug regimen and DBP –3.9 (–5.2 to –2.6) and control of BP
>140 mmHg) regular review Control 0.4 (0.3 to 0.6)
(2) Usual care from their own family doctors
Park Hypertension ≥140/90 mmHg (1) Pharmacist administered monthly patient SBP –13.0 (–22.6 to –3.4) Positive RCT
et al56 management: education, medication changes DBP –5.0 (–9.9 to –0.1)
verbal counselling and written information Control 0.2 (0.1 to 0.8)
(2) Traditional pharmacy services
Solomon Treated patients with hypertension (1) Patient-centred pharmaceutical care SBP –6.9 (–12.7 to –1.1) Positive effect SBP,
et al57 model (employing standardised care) DBP –0.1 (–4.4 to 3.2) no effect DBP
implemented by clinical pharmacy residents Control not reported
(2) Usual care
De Castro A total of 71 patients in a single (1) C — under routine clinical management SBP –5.00 (–12.13 to 2.13) No significant effect for SBP
et al58 hospital clinic outpatient in Brazil. and sham intervention DBP –2.00 (–7.11 to 3.11) and DBP
>18 years with uncontrolled (2) Intervention — received a pharmaceutical Control not reported
hypertension care programme delivered by 9 trained
pharmacists: patient education and support
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Schroeder 245 women and men recruited with Participants were randomised to receive (1) SBP –1.70 (–6.42 to 3.02) No effect on SBP or DBP or
et al59 uncontrolled hypertension (> or = nurse-led adherence support or (2) usual care DBP –0.10 (–2.54 to 2.34) medication adherence
150/90 mmHg) from 21 general alone. Control not reported
practices in Bristol, UK. All patients
with hypertension coded and latest
BP ≤150/90
SookaneknunAdults with hypertension from (1) Patients were monitored monthly by SBP –5.70 (–10.28 to –1.12) Positive effect for SBP, DBP
et al60 hospital and 2 primary care units reviewing their medications and supported by DBP –2.50 (–5.61 to 0.61) and BP control
providing pharmaceutical care and counseling. Control 0.69 (0.41 to 1.17)
(2) usual care
Tobe et al61 Diagnosis of hypertension with 1) Medical clinic measurement of blood SBP –7.00 (–13.45 to –0.55) Positive effect for SBP
SBP greater or equal to 130 mmHg pressure by home care nurse using BpTRU DBP –0.80 (–5.12 to 3.52)
DBP greater or equal to 80 mmHg automated oscillometric blood pressure cuff Control not reported
Diagnosis of type 2 diabetes (2) Healthy lifestyle classes stressing a healthier
mellitus dietary regimen, exercise, smoking cessation
and drug adherence
Tonstad Subjects that participated in a Randomly allocated either to (1) monthly SBP 0.00 (–5.30 to 5.30) No effect on SBP or DBP
et al62 health screening with systolic blood nurse-led lifestyle counselling (intervention DBP –1.00 (–4.81 to 2.81)
pressure 140–169 mmHg and group, n = 31) or to (2) conventional primary Control not reported
diastolic blood pressure care (control group, n = 20) to be followed by
90–99 mmHg at a minimum of lifestyle counselling.
three separate readings treated or not
treated with antihypertensive drugs.
Bulpitt Hypertension, mean BP (1) Computer-held records: allowed doctor SBP –0.4 (–5.9 to 5.1) No effect RCT
et al63 178/105 mmHg (intervention) to record clinical information in structured DBP 0.2 (–2.6 to 3.0)
177/106 mmHg (Control) format Control not reported
(2) Standard hospital notes
Hypertension Hypertension DBP (1) Stepped care, designed to provide (1) Stratum 1: 90–104 Positive RCT, reduction
Detection and ≥90 mmHg rigorous, systematic, antihypertensive SBP –8.2 (–9.2 to –7.1) in all cause mortality as well
Follow up drug treatment with: free care; emphasis DBP –4.2 (–4.7 to –3.7)
(HDFP)64–66 placed on clinic attendance and compliance; (2) Stratum 2: 105–114 mmHg
convenience; stepped drug treatment SBP –11.7 (–13.7 to –9.7)
according to BP response; patients seen DBP –7.6 (–9.2 to –6.0)
at intervals determined by their clinic status, (3) Stratum 3: ≥115 mmHg
at least every 4 months, and generally every SBP –10.6 (–13.7 to –7.5)
2 months DBP –6.5 (–7.4 to –5.6)
(2) Referred care: referred to their ‘primary Control 0.4 (0.3 to 0.5)
sources of care, usually own physicians
Takala Hypertension, aged 40–49 years, (1) ‘Improved treatment system’ included: Age 40–49 No effect RCT but improved
et al67,68 SBP ≥160 mmHg or DBP written instructions; card with details of BP SBP 3.0 (–5.1 to 11.1) follow-up at clinic
≥95 mmHg; aged 50–64 years, readings, drugs prescribed, time of next DBP 3.0 (–1.1 to –7.1)
SBP ≥170 mmHg or DBP appointment; appointments at 1-monthly Age 50–59
≥105 mmHg. intervals; invitation for outpatient review; SBP 3.0 (–5.5 to 11.5)
appointment if defaulted on any appointment DBP 5.0 (0.7 to 9.3)
(2) Usual care Control 0.5 (0.2 to 1.0)
Turnbull Mild to moderate hypertension and (1) Information communication technology SBP –0.70 (–4.41 to 3.01) No effect on SBP and DBP
et al69 aged between 18 and 75 years. package for risk assessment and management, DBP –0.10 (–1.75 to 1.55) and blood pressure control
access to a dietitian commissioned by the Control 1.90 (1.14 to 3.19)
program and a tailored set of audiovisual and
written material.
(2) Usual care
Wetzels Persons were eligible if had been A total of 258 patients with high BP despite use SBP –2.00 (–7.04 to 3.04) No effect on SBP and DBP
et al70 diagnosed with hypertension and of antihypertensive medication were randomly DBP –1.00 (–3.57 to 1.57) and blood pressure control
inadequate BP control despite assigned to either (1) continuation of usual care Control 0.69 (0.40 to 1.19)
drugs and indication for or to the (2) introduction of electronic monitoring.
Rx escalation
Ahluwalia Patients with hypertension (1) Mailed reminder: postcard addressed in Return to clinic 1.4 No effect RCT
et al71 (SBP ≥180 mmHg and/or the presence of the patient and mailed next (0.5 to 4.4)
DBP ≥110 mmHg) day as a reminder to attend clinic
(2) Given routine clinic appointment
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Barnett Hypertension (1) Computer reminder to GP: generated Return to clinic 0.01 Positive RCT
et al72 mean 150/102 mmHg automatic reminder to GP (0.0 to 0.2)
(2) Usual care
Bloom Hypertension ≥140/90 mmHg (1) Educational material about hypertension, Return to clinic 0.3 Positive RCT
et al73 reinforced 1 week later (0.1 to 0.9)
(2) Usual care
Cummings Newly diagnosed hypertension (1) Appointment reminder: reminder card Return to clinic 0.5 Positive RCT
et al74 SBP <140 mmHg and DBP sent 1 week in advance of appointment (0.3 to 0.7)
>90 mmHg and telephone patients who missed
appointments to schedule new ones
(2) Usual care
Fletcher Hypertension DBP ≥100 mmHg (1) Reminder (letter or phone) to attend follow Return to clinic 0.3 Positive RCT
et al75 up appointment at clinic, offer of assistance (0.2 to 0.7)
if problems arose, followed up until attended
clinic or missed two consecutive appointments
(2) Usual care
Krieger Hypertension SBP ≥140 mmHg (1) Outreach and tracking by community Return to clinic Positive RCT
et al76 or DBP≥90 mmHg health worker 0.5 (0.3 to 0.7)
(2) Usual care
Marquez Eighty-five primary care centers in (1) Control – under routine clinical management; Mail intervention Positive effect on SBP, DBP
et al77 Spain, with a duration of 6 months. (2) Mail intervention – received a mailed SBP –0.30 (–3.05 to 2.45) and blood pressure control
Patients. A total of 636 patients message reinforcing compliance and reminding DBP –7.10 (–12.05 to –2.15)depending on intervention
with newly diagnosed or of the visits (15 days, 2 and 4 months) Control
uncontrolled hypertension (3) Telephone intervention – received a telephone 0.52 (0.34 to 0.79)
were included. call at 15 days, then at 7 and 15 weeks. Telephone intervention
SBP –9.50 (–11.95 to –7.05)
DBP –0.20 (–1.91 to 1.51)
Control 0.57 (0.37 to 0.87)
Marquez All patients were receiving (1) Patients in the control group received their SBP 4.70 (–1.29 to 10.69) No effect SBP, DBP and
et al78 monotherapy for uncontrolled physician’s usual interventions. DBP 1.60 (–2.10 to 5.30) blood pressure control
hypertension. (2) Patients in the intervention group received Control 0.58 (0.22 to 1.54)
messages and reminders sent to their mobile
phones 2 days per week during 4 months.
aOutcomes: SBP and DBP mean difference in mmHg is reported. Negative figure favours intervention, positive figure favours control or usual care. Control of
blood pressure measured according to treatment target definition in each RCT. Odds ratio less than one favours intervention. Return to Clinic: number of patients
lost to follow-up at review. Odds ratio less than one favours intervention. BP = blood pressure. C = control. CVS = cardiovascular. DBP = diastolic blood pressure. E
= experimental group. OPD = outpatient department. RCT = randomised controled trial. SBP = systolic blood pressure. TIME = Treatment Information on Medications
for the Elderly.
Appendix 2 continued. Characteristics of included randomised controlled trials
